In September 2022, Gan & Lee Pharmaceuticals participated in the 58th Annual European Association for the Study of Diabetes (EASD) Conference in Stockholm, Sweden. The conference, organized by the European Association for the Study of Diabetes, attracts leading physicians, scientists and healthcare professionals from around the world through a combination of online and offline formats, providing the medical community with an opportunity to learn about diabetes cutting-edge technologies, groundbreaking research findings and a significant advances in the direction of treatment and care. For the first time, Gan & Lee Pharmaceuticals met with global experts in the field of diabetes in the form of an offline exhibition for academic exchange and discussion at the EASD Annual Meeting.